[Ambulant long-term treatment of arterial hypertension].
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002740:Chlorothiazide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D006974:Hypertension, Malignant / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D051381:Rats; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D006830:Hydralazine; D008750:Methyldopa; D002740:Chlorothiazide; D012110:Reserpine; D006145:Guanethidine
Die ambulante Langzeitbehandlung der arteriellen Hypertonie.